Previous studies have reported that cancer vaccines in combination with IL-7 induced a higher proportion of specific CD8+ and CD4+ memory T cells in mice models bearing tumors and improve the functionality of specific CD8+ memory T cells by enhancing their IFN-γ secretion (81, 84). The gene discussed is IFNG; the disease is cancer.